PAVmed Inc. Deferred Tax Liabilities, Deferred Expense, Capitalized Patent Costs
PAVmed Inc. (PAVM) had Deferred Tax Liabilities, Deferred Expense, Capitalized Patent Costs of $36.00 thousand as of 2021-12-31, per its 10-K filed 2023-03-14.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities
us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedPatentCosts · last filed 2023-03-14
- 2021-12-31: Deferred Tax Liabilities, Deferred Expense, Capitalized Patent Costs $36.00K.
| Period end | Deferred Tax Liabilities, Deferred Expense, Capitalized Patent Costs |
|---|---|
| 2021-12-31 | $36.00K 10-K · filed 2023-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InspireMD, Inc. (NSPR) | $0.033B | ||
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |